| LAES | PRESS-RELEASE | neutral | 4/10 | SEALSQ signed a binding letter of intent to acquire satellite capacity and ground infrastructure from WISeSat.Space for | Oct 26, 2026 |
| FELE | PRESS-RELEASE | neutral | 2/10 | Franklin Electric declared a quarterly cash dividend of $0.28 per share, payable November 19, 2026, to shareholders of r | Oct 26, 2026 |
| SAIQ | PRESS-RELEASE | neutral | 4/10 | WISeSat.Space announced a binding letter of intent with sister company SEALSQ Corp for a ~$15 million acquisition of cap | Oct 26, 2026 |
| SYK | PRESS-RELEASE | neutral | 4/10 | Stryker has completed the acquisition of ZuriMED, a privately held developer of the FiberLocker System. The deal value a | Oct 26, 2026 |
| BTCS | PRESS-RELEASE | neutral | 3/10 | BTCS announced a cash tender offer to repurchase up to $500,000 of its Series V Preferred Stock via a modified Dutch auc | Oct 26, 2026 |
| SENS | PRESS-RELEASE | neutral | 4/10 | Senseonics announced the initiation of a first-in-human clinical study for its investigational 'Freedom' CGM system, whi | Oct 26, 2026 |
| VHUB | PRESS-RELEASE | neutral | 4/10 | VenHub Global announced a strategic partnership with Follett Higher Education to deploy its autonomous Smart Stores acro | Oct 26, 2026 |
| RACE | PRESS-RELEASE | neutral | 2/10 | Ferrari disclosed weekly buyback activity under its third tranche of a multi-year €3.5B buyback program. From Oct 19-23, | Oct 26, 2026 |
| QUCY | PRESS-RELEASE | neutral | 2/10 | Quantum Cyber presented its antenna technology at QuantumCT's Phase 3 Pilot Collaboration RFP Convening on Quantum Sensi | Oct 26, 2026 |
| OPTT | PRESS-RELEASE | neutral | 3/10 | Ocean Power Technologies announced a non-binding LOI with Stratum Holdings for a strategic collaboration to demonstrate | Oct 26, 2026 |
| DAVI | PRESS-RELEASE | neutral | 4/10 | Davion Healthcare Plc acquired the IP of two medical technologies (WoundSkan smart wound dressing and Spektra lateral fl | Oct 26, 2026 |
| XLO | PRESS-RELEASE | neutral | 4/10 | Xilio Therapeutics announced dosing of the first patient in a Phase 1/2 trial of XTX501, a PD-1/masked IL-2 bispecific, | Oct 26, 2026 |
| IMRX | PRESS-RELEASE | neutral | 3/10 | Immuneering presented a trial-in-progress poster at ESMO 2026 for its pivotal Phase 3 trial (MAPKeeper 301) evaluating a | Oct 26, 2026 |
| DAIC | PRESS-RELEASE | neutral | 2/10 | CID Holdco (Dot Ai, DAIC) appointed Avi Cohen to its board of directors. Cohen has experience leading technology compani | Oct 26, 2026 |
| MGNX | PRESS-RELEASE | bullish | 6/10 | MacroGenics announced positive interim Phase 2 LINNET data for lorigerlimab in clear cell gynecologic cancer (CCGC), sho | Oct 26, 2026 |
| HBT | PRESS-RELEASE | neutral | 5/10 | HBT Financial reported Q3 2026 adjusted EPS of $0.86, beating the $0.79 consensus by 8.9%, with net interest income of $ | Oct 26, 2026 |
| ABOS | PRESS-RELEASE | neutral | 5/10 | Acumen Pharmaceuticals reported a Q3 2026 net loss of $25.4M ($0.35 per share), slightly narrower than the year-ago $26. | Oct 26, 2026 |
| VZ | PRESS-RELEASE | neutral | 5/10 | Verizon reported Q3 2026 GAAP EPS of $1.25 (up 6.8% YoY) and Adjusted EPS of $1.31 (up 8.3% YoY), slightly below the $1. | Oct 26, 2026 |
| REGN | PRESS-RELEASE | neutral | 3/10 | Regeneron expanded its existing BARDA procurement agreement for Inmazeb, its FDA-approved Ebola treatment, adding approx | Oct 26, 2026 |
| AZO | PRESS-RELEASE | neutral | 3/10 | AutoZone announced CFO Jamere Jackson's resignation effective November 25, 2026, to join FedEx. An external search for a | Oct 26, 2026 |
| LKFN | PRESS-RELEASE | neutral | 5/10 | Lake City Bank (LKFN) reported Q3 2026 net income of $28.9M (record), up 9% YoY, with diluted EPS of $1.14 beating the $ | Oct 26, 2026 |
| VAI | PRESS-RELEASE | bearish | 5/10 | Valor Energy announced a $5M private placement of 2.1M shares at $2.33/share to fund its proposed $3.6M acquisition of a | Oct 26, 2026 |
| EIKN | PRESS-RELEASE | bullish | 6/10 | Eikon Therapeutics presented updated Phase 2 data for its TLR7/8 agonist EIK1001 in first-line stage 4 NSCLC at ESMO 202 | Oct 26, 2026 |
| EQT | PRESS-RELEASE | mixed | 7/10 | EQT Corporation will acquire Range Resources in an all-stock transaction valued at 0.987 EQT shares per Range share, cre | Oct 26, 2026 |
| BNTX | PRESS-RELEASE | bearish | 6/10 | BioNTech and DualityBiologics announced that the Phase 3 DYNASTY-Breast02 trial of trastuzumab pamirtecan (BNT323/DB-130 | Oct 26, 2026 |
| NXPI | PRESS-RELEASE | bullish | 6/10 | NXP Semiconductors has been selected as a strategic technology partner by Volkswagen Group, with its S32K5 microcontroll | Oct 26, 2026 |
| HCM | PRESS-RELEASE | bullish | 7/10 | HUTCHMED announced positive Phase III SANOVO trial results for ORPATHYS (savolitinib) plus TAGRISSO (osimertinib) in fir | Oct 26, 2026 |
| ESLT | PRESS-RELEASE | neutral | 4/10 | Elbit Systems announced approximately $200 million in contracts from an Asia-Pacific country for airborne ISTAR, trainin | Oct 26, 2026 |
| CTSH | PRESS-RELEASE | neutral | 3/10 | Cognizant announced a five-year strategic partnership with the European Bank for Reconstruction and Development (EBRD) t | Oct 26, 2026 |
| OPNW | PRESS-RELEASE | neutral | 3/10 | OpenWorld confirmed its planned dual listing on Figure OPEN remains on track for Q4 2026, with stockholder approval of t | Oct 25, 2026 |